-
UK’s MHRA starts rolling review of Moderna’s COVID-19 vaccine
pharmatimes
October 29, 2020
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has begun the rolling review process of Moderna’s COVID-19 vaccine candidate, mRNA-1273.
-
UK to collaborate with Oxford Immunotec to evaluate COVID-19 vaccine T cell responses
expresspharma
October 23, 2020
T cell immunity is thought to be essential to protect against infection from the SARS-COV-2 coronavirus and could provide longer-term immunity than antibodies.
-
UK to establish human challenge studies for COVID-19 vaccines
europeanpharmaceuticalreview
October 22, 2020
The UK government hopes to expedite the development of a COVID-19 vaccine by investing £33.6 million in the first phase of establishing human challenge trials.
-
Asthma fund launched to support development and adoption of new technologies
pharmatimes
October 22, 2020
A new fund aiming to support the development and adoption of technology for people with asthma has been created by Asthma UK and the British Lung Foundation alongside the National Institute for Health Research (NIHR) and the Engineering and ...
-
Epsilogen awarded £1m grant from Innovate UK
pharmatimes
October 22, 2020
London-based Epsilogen has been awarded a £1m grant from the UK’s innovation agency Innovate UK to further develop a novel immunoglobulin E (IgE) antibody to treat cancer.
-
UK and hVIVO to develop Covid-19 human study model
pharmaceutical-technology
October 22, 2020
The UK Government has signed a contract with Open Orphan subsidiary hVIVO for the development of a Covid-19 human challenge study model.
-
Experts partner with UK government for COVID-19 human challenge trials
pharmatimes
October 22, 2020
The UK government has joined forces with experts from the NHS, academia and the private sector to explore and establish human challenge trials to aid the development of a COVID-19 vaccine.
-
UCB acquires new campus to support UK operations
pharmatimes
October 22, 2020
Belgian pharma company UCB has agreed to acquire a new campus to further support its operations in the UK.
-
ABPI chief exec says no-deal Brexit is ‘not in the interest of patients’
pharmatimes
October 21, 2020
Following prime minister Boris Johnson’s announcement last week that he was preparing for a no-deal with the EU, the Association for the British Pharmaceutical Industry (ABPI) has warned against such an outcome.
-
Telstar’s centre in the UK consolidates its business growth with move to new higher-capacity modern installation
europeanpharmaceuticalreview
October 21, 2020
Specialised in aseptic and containment barrier Isolation technology systems, Telstar UK has seen increased demand for its products from all across the life sciences sector has grown significantly in the past few years.